740-57-8 Usage
Description
H-PHE-BETANA, also known as L-phenylalanine amide, is an L-phenylalanine derivative obtained by formal condensation of the carboxy group of L-phenylalanine with the amino group of 2-naphthylamine. It is a white powder with unique chemical properties.
Uses
Used in Pharmaceutical Industry:
H-PHE-BETANA is used as a pharmaceutical intermediate for the synthesis of various drugs and medications. Its unique chemical structure allows it to be a key component in the development of new therapeutic agents.
Used in Research and Development:
H-PHE-BETANA is used as a research compound in the field of organic chemistry and biochemistry. Its unique properties make it a valuable tool for studying various chemical reactions and biological processes.
Used in Cosmetic Industry:
H-PHE-BETANA is used as an active ingredient in cosmetic products for its potential skin care benefits. Its unique chemical structure may contribute to improving skin health and appearance.
Used in Food Industry:
H-PHE-BETANA is used as a flavoring agent in the food industry. Its unique chemical properties may contribute to enhancing the taste and aroma of various food products.
Check Digit Verification of cas no
The CAS Registry Mumber 740-57-8 includes 6 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 3 digits, 7,4 and 0 respectively; the second part has 2 digits, 5 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 740-57:
(5*7)+(4*4)+(3*0)+(2*5)+(1*7)=68
68 % 10 = 8
So 740-57-8 is a valid CAS Registry Number.
InChI:InChI=1/C19H18N2O/c20-18(12-14-6-2-1-3-7-14)19(22)21-17-11-10-15-8-4-5-9-16(15)13-17/h1-11,13,18H,12,20H2,(H,21,22)/t18-/m0/s1
740-57-8Relevant articles and documents
Addressing the stability of C-capped dipeptide efflux pump inhibitors that potentiate the activity of levofloxacin in Pseudomonas aeruginosa
Renau, Thomas E,Leger, Roger,Flamme, Eric M,She, Miles W,Gannon, Carla L,Mathias, Kristina M,Lomovskaya, Olga,Chamberland, Suzanne,Lee, Ving J,Ohta, Toshiharu,Nakayama, Kiyoshi,Ishida, Yohei
, p. 663 - 667 (2007/10/03)
Synthetic optimization of a biologically labile class of dipeptides that function as efflux pump inhibitors to potentiate the antibacterial agent levofloxacin in Pseudomonas aeruginosa has led to the discovery of a related series of compounds that are completely stable in a variety of biological matrices. Other than the stability profile, the in vitro profile of the new series is essentially identical to that observed with the original one. A prototypical compound from the new series demonstrates potentiation in an in vivo model of infection.